LOCATE BIO LIMITED

Active Nottingham

Other research and experimental development on natural sciences and engineering

15 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
L

LOCATE BIO LIMITED

Other research and experimental development on natural sciences and engineering

Founded 20 Apr 2001 Active Nottingham, United Kingdom 15 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering

Previous Company Names

LOCATE THERAPEUTICS LIMITED 25 Apr 2014 — 8 Oct 2018
REGENTEC LTD. 20 Apr 2001 — 25 Apr 2014
Accounts Submitted 24 Apr 2025 Next due 31 Jul 2026 3 months remaining
Confirmation Submitted 10 Mar 2026 Next due 20 Mar 2027 11 months remaining
Net assets £10M £6M 2024 year on year
Total assets £11M £6M 2024 year on year
Total Liabilities £511K £356K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

Medicity Thane Road Beeston Nottingham NG90 6BH

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for LOCATE BIO LIMITED (04202562), an active life sciences and medical technology company based in Nottingham, United Kingdom. Incorporated 20 Apr 2001. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£7.87M

Increased by £4.87M (+162%)

Net Assets

£10.16M

Increased by £6.39M (+169%)

Total Liabilities

£510.76k

Decreased by £355.99k (-41%)

Turnover

N/A

Employees

15

Decreased by 1 (-6%)

Debt Ratio

5%

Decreased by 14 (-74%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 1

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 5Oct 2018Seed
Investor 3May 2019Seed
Investor 1Sept 2021Series A

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 18,255,955 Shares £20.00m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Nov 2025112,500£11.25£0
25 Nov 2024126,747$175k$1.381
25 Nov 2024327,588AUD700kAUD2.137
16 Apr 2024399,079AUD833kAUD2.087
16 Apr 2024321,100£350k£1.09

Officers

Officers

2 active 1 resigned
Status
Valentine, Keith CharlesDirectorAmericanUnited States585 Jan 2021Active
Von Benecke, John PaulDirectorBritishUnited Kingdom532 Sept 2019Active

Shareholders

Shareholders (53)

Mercia (general Partner) Limited As General Partner Of Mercia Investment Plan Lp
15.1%
4,915,904
Bgf Investments Lp
12.4%
4,030,434

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 1 Sept 2021
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

LOCATE BIO LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Mar 2026Confirmation StatementConfirmation statement made on 2026-03-06 with updates
28 Nov 2025CapitalAllotment of shares (GBP 934.127292) on 2025-11-28
21 Nov 2025OfficersTermination of Colin Ian Thomson as director on 2025-11-21
18 Sept 2025OfficersTermination of Alex Stephen Gwyther as director on 2025-09-17
18 Sept 2025OfficersAppointment of Mercia Fund Management (Nominees) Limited as director on 2025-09-17
10 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-03-06 with updates

28 Nov 2025 Capital

Allotment of shares (GBP 934.127292) on 2025-11-28

21 Nov 2025 Officers

Termination of Colin Ian Thomson as director on 2025-11-21

18 Sept 2025 Officers

Termination of Alex Stephen Gwyther as director on 2025-09-17

18 Sept 2025 Officers

Appointment of Mercia Fund Management (Nominees) Limited as director on 2025-09-17

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-06 with updates

1 months ago on 10 Mar 2026

Allotment of shares (GBP 934.127292) on 2025-11-28

4 months ago on 28 Nov 2025

Termination of Colin Ian Thomson as director on 2025-11-21

4 months ago on 21 Nov 2025

Termination of Alex Stephen Gwyther as director on 2025-09-17

7 months ago on 18 Sept 2025

Appointment of Mercia Fund Management (Nominees) Limited as director on 2025-09-17

7 months ago on 18 Sept 2025